Patents
Patents for C07C 327 - Thiocarboxylic acids (5,460)
12/2002
12/12/2002US20020187542 Fatty-acid amide hydrolase
12/12/2002CA2450118A1 Insecticidal biphenylthiohydrazides
12/12/2002CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/11/2002EP1264547A1 Flavour and fragrance compositions
12/10/2002US6492562 Invention also relates to novel intermediates and the resulting modified polyketides and antibiotics.
12/10/2002US6492405 Compounds containing sulfhydryl, disulfide, or group(s) capable of being converted in-vivo to a sulfhydryl group, and at least one nitrate group; use as substitutes for existing tolerance-inducing nitric oxide donors
12/10/2002US6492370 Urea derivatives and pharmaceutical compositions thereof
12/10/2002CA2036360C Reagents and methods for stereospecific fluoromethylation
12/05/2002WO2002097393A2 Cleavable surfactants and methods of use thereof
12/05/2002US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/2002
11/28/2002US20020177622 Neuroprotectants; enhancing cognition
11/27/2002EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002CN1381444A Method for preparing flixonase and its correlative 17 bata-carbothionate using carbothioic acid synthetic method and extraction method
11/21/2002WO2002060340A9 Method for identifying maxi-k channel blockers
11/20/2002EP1257531A2 Method for the preparation of carbothioic acids
11/19/2002US6482978 Production method of aromatic carboxylic acid derivative
11/19/2002US6482853 Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery
11/19/2002US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/12/2002US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/07/2002WO2002088061A1 Novel atisane compound and use thereof
11/07/2002US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/06/2002CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/05/2002WO2001085673A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002CA2408209A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
10/2002
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002US20020161235 Compounds containing sulfhydryl, disulfide, or group(s) capable of being converted in-vivo to a sulfhydryl group, and at least one nitrate group; use as substitutes for existing tolerance-inducing nitric oxide donors
10/30/2002CN1376672A O-substituted benzene (alkyl) sulfenyl benzoic acid as plant growth regulator
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/24/2002US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/23/2002EP1251115A1 Process for producing optically active carboxylic acid substituted in 2-position
10/22/2002US6469207 Hiv protease inhibitors; administering to treat aids (acquired immune deficiency syndrome)
10/22/2002US6469146 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
10/22/2002US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002US6468406 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
10/17/2002WO2002081437A2 Novel n-p-propargyloxyphenethyl-thioacetic acid amides
10/17/2002US20020151546 HIV protease inhibitors based on amino acid derivatives
10/16/2002EP1249446A2 Use of thio derivates as perfuming and flavoring ingredients
10/15/2002US6465646 1-alkoxy and 1-acyloxy substituted cyclohex-1-ene compounds and sulfur and 1-alkoxycarbonyl analogs having retinoid-like biological activity
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002CA2112690C Amino acid derivative
10/10/2002US20020147234 Nitrate esters and methods of making same
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/03/2002WO2002064583A3 Bis(alkylthio)carbenium salts
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002US20020143187 Nitric oxide donors and pharmaceutical compositions containing them
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
10/01/2002US6458968 Dithiocarboxylic ester synthetic process
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
09/2002
09/26/2002WO2002074724A1 Method for aldol reaction in water
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002US20020137942 HIV protease inhibitors; administering to treat AIDS (acquired immune deficiency syndrome)
09/26/2002US20020137775 Novel delta dicarbonyl compounds and methods for using the same
09/24/2002US6455581 Inhibitors of hiv protease.
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/19/2002US20020133032 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
09/17/2002US6451859 C16 unsaturated FP-selective prostaglandins analogs
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/17/2002CA2041832C Hydrazones
09/12/2002US20020128266 ABCA-1 elevating compounds
09/11/2002EP1237860A1 Calixarenes
09/11/2002CN1368956A Carbamate derivatives and agricultural/horticultural bactericides
09/10/2002USRE37839 Fungicides, insecticides, miticides, nematocides, and pesticides
09/10/2002US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/06/2002WO2002068592A2 Non-racemic hexafluoreleucine, and methods of making and using it
08/2002
08/29/2002WO2002022849A3 Enzymatic resolution of aryl- and thio-substituted acids
08/29/2002US20020120149 Substituted hydrazine derivatives
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/27/2002US6441036 Treating atherosclerosis and insulin resistance
08/27/2002CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them
08/22/2002WO2002064583A2 Bis(alkylthio)carbenium salts
08/22/2002WO2002064554A1 Cyanothioacetamide derivative and process for producing the same
08/22/2002WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002DE10106577A1 Bis(alkylthio)carbeniumsalze Bis (alkylthio) carbenium
08/21/2002EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
08/20/2002US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders
08/15/2002US20020111512 Dynamic resolution of isomers and resolved isomers
08/15/2002US20020111364 ABCA-1 elevating compounds
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002CN1364153A Substituted phenoxyacetic acids
08/08/2002WO2002060863A1 Ophthalmic compositions for treating ocular hypertension
08/08/2002WO2002060340A2 Method for identifying maxi-k channel blockers
08/08/2002US20020107234 Lipoic acid derivatives and their use in treatment of disease
08/08/2002CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 55